Project Grant HT94252410010
Award Date
2/1/24
Completion Date
1/31/26
Dollars Obligated
$220K
Federal Agency
Defense Health Agency
Awardee
Universitat Bern (MX7JPQLVM5V5)
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Switzerland
Similar Awards
The U.S. Defense Health Agency awarded a $989,167 Project Grant to the University of Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant, effective from February 15, 2024 to February 14, 2027, supports research to define the role of the SWI/SNF chromatin remodeling complex in advanced metastatic castration-resistant prostate cancer (mCRPC) therapy resistance. Through this grant, the University of Bern will conduct basic, translational, and...
This federal Project Grant award, valued at $548,133.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Basel in Switzerland focused on "Neuronal Regulation of Antitumor Immunity". The award, which began on September 15, 2024 and is scheduled for completion by September 14, 2027, aims to conduct advanced biomedical research investigating the role of neuronal processes in...
The Department of the Army Medical Command awarded a $438,916 project grant to Universitat Bern in Switzerland under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 1, 2022 to August 31, 2026 to target PARP inhibitor resistance. Through this funding, Universitat Bern researchers will investigate medical solutions for targeting resistance to poly (ADP-ribose) polymerase inhibitors, an area of focus under the Military Medical...
The University of California, San Diego (UCSD) was awarded a $1,580,000 Project Grant from the Defense Health Agency's Military Medical Research and Development (CFDA 12.420) program. The grant, effective March 1, 2025 through February 29, 2028, will support "MULTIOMIC APPROACHES FOR NONINVASIVE PREDICTION OF INFLAMMATORY BOWEL DISEASE EXACERBATIONS." This research aims to transform healthcare for military service members, veterans, and the broader public through innovative...
The University of Queensland in Australia was awarded a $296,964 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2023 to February 28, 2025 to investigate epithelial tissue mechanics as a potential new factor in relapse for chronic inflammatory bowel disease. Through this funding, researchers aim to gain insights that could transform healthcare for service members and the public by...
This Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $187,821.00 to Universitat Bern in Switzerland to conduct research on "site-specific intra-articular 'on demand' immunosuppression for long term functional graft survival in joint allotransplantation in a large-animal model." The goal of this research is to develop new immunosuppressive therapies to improve outcomes for joint transplantation procedures. The...
The Defense Health Agency awarded a $199,966 project grant to the Ecole Polytechnique Federale De Lausanne (EPFL) in Switzerland under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. Specifically, the funding will be used to conduct research on the foundations supporting neuroprosthetic management of hypotensive complications in...
This federal Project Grant award of $533,875.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports Brown University's research to develop ultrasensitive stool tests for Line-1 ORF1P detection to aid in gastric cancer diagnosis. The award, effective June 1, 2025 through May 31, 2027, will enable Brown University's innovative research to advance early detection capabilities for this form of cancer. The Military Medical Research and Development...
The Defense Health Agency awarded a $311,000 Project Grant to the University of Washington under the Military Medical Research and Development federal grant program (CFDA 12.420) to manage mitochondrial disorders through increased intestinal fermentation and reduced metabolic burden from January 1, 2023 to December 31, 2024. The University of Washington will deliver research to transform health care for service members and the public by investigating medical solutions for the battlefield through...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $239,735 to Universitaet Heidelberg (UNI Heidelberg) to conduct research on how the tight-packing of bacteria in Mycobacterium tuberculosis biofilms impacts antibiotic therapy. The research project, titled "HANG TOGETHER OR HANG SEPARATELY: UNDERSTANDING HOW THE TIGHT-PACKING OF BACTERIA IN M TUBERCULOSIS BIOFILMLIKE CORDS IMPACTS ANTIBIOTIC...